Latest Valeant Pharmaceuticals Stories
MarketOptimizer.org adds “Hyperemia Global Clinical Trials Review, H2, 2014” to its store.
LAVAL, Quebec, Sept. 30, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
IRVINE, Calif., Sept.
LAVAL, Quebec, Sept. 25, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that its Board of Directors has appointed Jeffrey W.
Expect to file in the U.S. in First Half of Q2 2015 Expect to launch in the U.S. in First Half of 2016 Peak U.S.
Overall Same Store Organic Growth (unadjusted for generics) Expected to Exceed 15% in Third Quarter Bausch + Lomb Expected to Continue to Deliver Greater Than 10% Organic Growth
LAVAL, Quebec, Sept. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 9, 2014 /PRNewswire/ -- Today, Analysts Review released its research
Hosted Ribbon Cutting Ceremony for the New Bausch + Lomb ULTRA® Contact Lens Manufacturing Line and Solar Array Implementation LAVAL, Quebec, Sept.
With a fast growing multicultural healthcare practice, New York- and Denver-based XL Alliance looks to win award with its Hispanic campaign for calamine lotion Caladryl® NEW YORK,
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).